Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Juan García-Arriaza & Mariano Esteban. (2014) Enhancing poxvirus vectors vaccine immunogenicity. Human Vaccines & Immunotherapeutics 10:8, pages 2235-2244.
Read now
Read now
Carmen Elena Gómez, Beatriz Perdiguero, Juan García-Arriaza & Mariano Esteban. (2013) Clinical applications of attenuated MVA poxvirus strain. Expert Review of Vaccines 12:12, pages 1395-1416.
Read now
Read now
. (2013) Landes Highlights. Bioengineered 4:1, pages 1-2.
Read now
Read now
Articles from other publishers (20)
Rani S. Sellers & Keith Nelson. 2023. Haschek and Rousseaux's Handbook of Toxicologic Pathology, Volume 2 : Safety Assessment Environmental Toxicologic Pathology. Haschek and Rousseaux's Handbook of Toxicologic Pathology, Volume 2 : Safety Assessment Environmental Toxicologic Pathology
335
396
.
Jilan A. Nazeam & Abdel Nasser B. Singab. (2022) Immunostimulant plant proteins: Potential candidates as vaccine adjuvants. Phytotherapy Research 36:12, pages 4345-4360.
Crossref
Crossref
Ingrid Andrêssa de Moura, Anna Jéssica Duarte Silva, Larissa Silva de Macêdo, Maria da Conceição Viana Invenção, Mylenna Máyra Gois de Sousa & Antonio Carlos de Freitas. (2022) Enhancing the Effect of Nucleic Acid Vaccines in the Treatment of HPV-Related Cancers: An Overview of Delivery Systems. Pathogens 11:12, pages 1444.
Crossref
Crossref
Karine Lélu, Clarisse Dubois, Alexei Evlachev, Morgane Crausaz, Marie Baldazza, Nadine Kehrer, Renée Brandely, Yasmin Schlesinger, Nathalie Silvestre, Jean-Baptiste Marchand, Bérangère Bastien, Stéphane Leung-Theung-Long, Jacqueline Unsinger, Perrine Martin & Geneviève Inchauspé. (2022) Viral Delivery of IL-7 Is a Potent Immunotherapy Stimulating Innate and Adaptive Immunity and Confers Survival in Sepsis Models. The Journal of Immunology 209:1, pages 99-117.
Crossref
Crossref
Shakila Harshavardhan, Kevin Kumar Vijayakumar & Vignesh Sounderrajan. 2021. A Mechanistic Approach to Medicines for Tuberculosis Nanotherapy. A Mechanistic Approach to Medicines for Tuberculosis Nanotherapy
213
227
.
Olusola Olagoke, Bonnie L. Quigley, Farhid Hemmatzadeh, Galit Tzipori & Peter Timms. (2020) Therapeutic vaccination of koalas harbouring endogenous koala retrovirus (KoRV) improves antibody responses and reduces circulating viral load. npj Vaccines 5:1.
Crossref
Crossref
Yik Chun Wong, Sarah Croft, Stewart A. Smith, Leon C. W. Lin, Tania Cukalac, Nicole L. La Gruta, Ingo Drexler & David C. Tscharke. (2019)
Modified Vaccinia Virus Ankara Can Induce Optimal CD8
+
T Cell Responses to Directly Primed Antigens Depending on Vaccine Design
. Journal of Virology 93:21.
Crossref
Crossref
Daniel Vázquez-Ramírez, Ingo Jordan, Volker Sandig, Yvonne Genzel & Udo Reichl. (2019) High titer MVA and influenza A virus production using a hybrid fed-batch/perfusion strategy with an ATF system. Applied Microbiology and Biotechnology 103:7, pages 3025-3035.
Crossref
Crossref
Stéphane Leung-Theung-Long, Charles-Antoine Coupet, Marie Gouanvic, Doris Schmitt, Aurélie Ray, Chantal Hoffmann, Huguette Schultz, Sandeep Tyagi, Heena Soni, Paul J. Converse, Lilibeth Arias, Patricia Kleinpeter, Benoît Sansas, Khisimuzi Mdluli, Cristina Vilaplana, Pere-Joan Cardona, Eric Nuermberger, Jean-Baptiste Marchand, Nathalie Silvestre & Geneviève Inchauspé. (2018) A multi-antigenic MVA vaccine increases efficacy of combination chemotherapy against Mycobacterium tuberculosis. PLOS ONE 13:5, pages e0196815.
Crossref
Crossref
Daniel Vázquez-Ramírez, Yvonne Genzel, Ingo Jordan, Volker Sandig & Udo Reichl. (2018) High-cell-density cultivations to increase MVA virus production. Vaccine 36:22, pages 3124-3133.
Crossref
Crossref
Mondher Toumi. 2017. Introduction to Market Access for Pharmaceuticals. Introduction to Market Access for Pharmaceuticals
107
116
.
Clement A. Meseda, Vajini Atukorale, Jordan Kuhn, Falko Schmeisser & Jerry P. Weir. (2016) Percutaneous Vaccination as an Effective Method of Delivery of MVA and MVA-Vectored Vaccines. PLOS ONE 11:2, pages e0149364.
Crossref
Crossref
Titus Sydler, Stefanie Brägger, Martin Handke, Sonja Hartnack, Fraser I. Lewis, Xaver Sidler & Enrico Brugnera. (2016) Latent porcine circovirus type 2-infected domestic pigs: A potential infection model for the effective development of vaccines against latent or chronic virus induced diseases. Vaccine 34:8, pages 1047-1053.
Crossref
Crossref
Stéphane Leung-Theung-Long, Marie Gouanvic, Charles-Antoine Coupet, Aurélie Ray, Emmanuel Tupin, Nathalie Silvestre, Jean-Baptiste Marchand, Doris Schmitt, Chantal Hoffmann, Murielle Klein, Philip Seegren, Maria C. Huaman, Anthony D. Cristillo & Geneviève Inchauspé. (2015) A Novel MVA-Based Multiphasic Vaccine for Prevention or Treatment of Tuberculosis Induces Broad and Multifunctional Cell-Mediated Immunity in Mice and Primates. PLOS ONE 10:11, pages e0143552.
Crossref
Crossref
Lucas Sánchez-Sampedro, Beatriz Perdiguero, Ernesto Mejías-Pérez, Juan García-Arriaza, Mauro Di Pilato & Mariano Esteban. (2015) The Evolution of Poxvirus Vaccines. Viruses 7:4, pages 1726-1803.
Crossref
Crossref
A. Katrin Helfer-Hungerbuehler, Andrea M. Spiri, Barbara Riond, Paula Grest, Felicitas S. Boretti & Regina Hofmann-Lehmann. (2015) No benefit of therapeutic vaccination in clinically healthy cats persistently infected with feline leukemia virus. Vaccine 33:13, pages 1578-1585.
Crossref
Crossref
Gina M Graziani & Jonathan B Angel. (2015) Evaluating the efficacy of therapeutic HIV vaccines through analytical treatment interruptions. Journal of the International AIDS Society 18:1, pages 20497.
Crossref
Crossref
Philip J. R. Price, Bruno Luckow, Lino E. Torres-Domínguez, Christine Brandmüller, Julia Zorn, Carsten J. Kirschning, Gerd Sutter & Michael H. Lehmann. (2014) Chemokine (C-C Motif) Receptor 1 Is Required for Efficient Recruitment of Neutrophils during Respiratory Infection with Modified Vaccinia Virus Ankara. Journal of Virology 88:18, pages 10840-10850.
Crossref
Crossref
Houda Boukhebza, Clarisse Dubois, Véronique Koerper, Alexei Evlachev, Yasmine Schlesinger, Thierry Menguy, Nathalie Silvestre, Petra Riedl, Geneviève Inchauspé & Perrine Martin. (2014) Comparative analysis of immunization schedules using a novel adenovirus-based immunotherapeutic targeting hepatitis B in naïve and tolerant mouse models. Vaccine 32:26, pages 3256-3263.
Crossref
Crossref
Karen R. Buttigieg, Stuart D. Dowall, Stephen Findlay-Wilson, Aleksandra Miloszewska, Emma Rayner, Roger Hewson & Miles W. Carroll. (2014) A Novel Vaccine against Crimean-Congo Haemorrhagic Fever Protects 100% of Animals against Lethal Challenge in a Mouse Model. PLoS ONE 9:3, pages e91516.
Crossref
Crossref